List view / Grid view
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The technology could enable patients with HIV to be managed more effectively in remote locations and can produce a result in under 30 minutes...
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
A new biologic medication - the first for HIV - is showing promise in treating patients with multidrug resistance, according to phase 3 research...
30 September 2016 | By Niamh Louise Marriott, Digital Content Producer
A simple set of alterations to a mouse’s living space, adding toys, caused dramatic changes to their T cells, making them a more protective inflammatory...
11 August 2016 | By Medical Research Council (MRC) Laboratory of Molecular Biology
HIV is surrounded by a protein shell called the capsid. It has now been found that HIV hides within the capsid while it builds DNA...
20 July 2016 | By Niamh Louise Marriott, Digital Content Producer
The NIH recently awarded $30 million to advance science towards a cure for HIV. Drug Target Review caught up with the Wistar Institute‘s Dr. Luis Montaner, co-leader of the BEAT-HIV project...
14 July 2016 | By Victoria White, Digital Content Producer
The US National Institutes of Health has awarded $30 million in annual funding to help advance science towards a cure for HIV...
29 June 2016 | By Victoria White, Digital Content Producer
A study suggests efavirenz might be an effective therapy for stimulating cholesterol turnover from the brain and slowing or preventing Alzheimer's disease...
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have described a strategy to stabilise an important HIV structure and potentially create HIV lookalikes for large-scale vaccine production...
11 April 2016 | By Victoria White, Digital Content Producer
Mymetics’ HIV vaccine candidate generated significant protection in groups of twelve female monkeys against repeated AIDS virus exposures...
6 April 2016 | By Victoria White
Scientists have described the first-ever immature antibody found in a powerful class of immune molecules effective against HIV. TSRI biologist Jiang Zhu called the antibody a “teenager” and said it gives scientists a unique view of the steps needed to prompt the immune system to effectively target HIV...
3 March 2016 | By Victoria White
According to the research, a drug for a disease that affects twice as many people will generate twice the revenue. But vaccine revenue depends on finer details about how the risk is distributed in the population...
25 February 2016 | By Victoria White
Data from the preclinical study support continued investigation of GS-9620 as part of an HIV eradication strategy…
14 January 2016 | By Victoria White
The Human Vaccines Project is a research programme designed to accelerate the development of vaccines by decoding the human immune system...
11 January 2016 | By Victoria White
The proceeds will support the development of Aelix’s lead candidate HTI immunogen as a therapeutic vaccine against HIV infection up to the completion of a Phase 2 proof-of-concept efficacy trial in HIV-infected individuals...
19 November 2015 | By Victoria White
A new study suggests that gamma interferon, which is an FDA-approved drug, may have potential as an antiviral therapy to prevent Ebola infection when given either before or after exposure to the virus...
